528 related articles for article (PubMed ID: 27523595)
1. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
2. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.
Vogel MME; Düsberg M; Stöhrer L; Dewes S; Sage EK; Borm KJ; Gschwend JE; Eiber M; Combs SE; Schiller K
Eur Urol Oncol; 2022 Dec; 5(6):668-676. PubMed ID: 36280446
[TBL] [Abstract][Full Text] [Related]
4. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates.
De Bruycker A; De Bleser E; Decaestecker K; Fonteyne V; Lumen N; De Visschere P; De Man K; Delrue L; Lambert B; Ost P
Eur Urol; 2019 May; 75(5):826-833. PubMed ID: 30503072
[TBL] [Abstract][Full Text] [Related]
5. Patterns of lymph node positivity on
McClinton C; Niroumand M; Sood S; Shah V; Hill J; Dusing RW; Shen X
Pract Radiat Oncol; 2017; 7(5):325-331. PubMed ID: 28377141
[TBL] [Abstract][Full Text] [Related]
6. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients.
Onal C; Ozyigit G; Guler OC; Hurmuz P; Torun N; Tuncel M; Dolek Y; Yedekci Y; Oymak E; Tilki B; Akyol F
Radiother Oncol; 2020 Oct; 151():222-227. PubMed ID: 32861704
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
Ramey SJ; Agrawal S; Abramowitz MC; Moghanaki D; Pisansky TM; Efstathiou JA; Michalski JM; Spratt DE; Hearn JWD; Koontz BF; Liauw SL; Pollack A; Anscher MS; Den RB; Stephans KL; Zietman AL; Lee WR; Stephenson AJ; Tendulkar RD
Eur Urol; 2018 Jul; 74(1):99-106. PubMed ID: 29128208
[TBL] [Abstract][Full Text] [Related]
8. Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.
Zumsteg ZS; Spratt DE; Romesser PB; Pei X; Zhang Z; Kollmeier M; McBride S; Yamada Y; Zelefsky MJ
J Urol; 2015 Dec; 194(6):1624-30. PubMed ID: 26165583
[TBL] [Abstract][Full Text] [Related]
9. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines.
Singh M; Maitre P; Mody R; Murthy V
Clin Oncol (R Coll Radiol); 2024 Jul; 36(7):445-451. PubMed ID: 38664178
[TBL] [Abstract][Full Text] [Related]
11. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
[TBL] [Abstract][Full Text] [Related]
12. Mapping of pelvic lymph node metastases in prostate cancer.
Joniau S; Van den Bergh L; Lerut E; Deroose CM; Haustermans K; Oyen R; Budiharto T; Ameye F; Bogaerts K; Van Poppel H
Eur Urol; 2013 Mar; 63(3):450-8. PubMed ID: 22795517
[TBL] [Abstract][Full Text] [Related]
13. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
14. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.
Meijer HJ; van Lin EN; Debats OA; Witjes JA; Span PN; Kaanders JH; Barentsz JO
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1405-10. PubMed ID: 21640507
[TBL] [Abstract][Full Text] [Related]
15. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.
Vargas CE; Galalae R; Demanes J; Harsolia A; Meldolesi E; Nürnberg N; Schour L; Martinez A
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1474-82. PubMed ID: 15964706
[TBL] [Abstract][Full Text] [Related]
16. Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
Hegemann NS; Wenter V; Spath S; Kusumo N; Li M; Bartenstein P; Fendler WP; Stief C; Belka C; Ganswindt U
Radiat Oncol; 2016 Mar; 11():37. PubMed ID: 26968955
[TBL] [Abstract][Full Text] [Related]
17. Influence of 3D-CRT pelvic irradiation on outcome in prostate cancer treated with external beam radiotherapy.
Pan CC; Kim KY; Taylor JM; McLaughlin PW; Sandler HM
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1139-45. PubMed ID: 12128113
[TBL] [Abstract][Full Text] [Related]
18. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer.
Tsuchida K; Inaba K; Kashihara T; Murakami N; Okuma K; Takahashi K; Igaki H; Nakayama Y; Maejima A; Shinoda Y; Matsui Y; Komiyama M; Fujimoto H; Ito Y; Sumi M; Nakano T; Itami J
Cancer Med; 2020 Sep; 9(18):6629-6637. PubMed ID: 32750234
[TBL] [Abstract][Full Text] [Related]
20. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
